Cranial flap fixation in sheep using a resorbable bone adhesive

View More View Less
  • 1 Department of Neurosurgery, University of Tennessee Health Science Center and Semmes Murphey Neurologic and Spine Institute, Memphis, Tennessee;
  • 2 Department of Neurosurgery, New England Baptist Hospital, Boston, Massachusetts;
  • 3 Department of Neurosurgery, Geisinger Health System, Danville, Pennsylvania;
  • 4 Stryker Corporation, Mahwah, New Jersey; and
  • 5 LaunchPad Medical, Lowell, Massachusetts
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

OBJECTIVE

The authors’ goal in this study was to investigate the use of a novel, bioresorbable, osteoconductive, wet-field mineral-organic bone adhesive composed of tetracalcium phosphate and phosphoserine (TTCP-PS) for cranial bone flap fixation and compare it with conventional low-profile titanium plates and self-drilling screws.

METHODS

An ovine craniotomy surgical model was used to evaluate the safety and efficacy of TTCP-PS over 2 years. Bilateral cranial defects were created in 41 sheep and were replaced in their original position. The gaps (kerfs) were completely filled with TTCP-PS (T1 group), half-filled with TTCP-PS (T2 group), or left empty and the flaps fixated by plates and screws as a control (C group). At 12 weeks, 1 year, and 2 years following surgery, the extent of bone healing, local tissue effects, and remodeling of the TTCP-PS were analyzed using macroscopic observations and histopathological and histomorphometric analyses. Flap fixation strength was evaluated by biomechanical testing at 12 weeks and 1 year postoperatively.

RESULTS

No adverse local tissue effects were observed in any group. At 12 weeks, the bone flap fixation strengths in test group 1 (1689 ± 574 N) and test group 2 (1611 ± 501 N) were both statistically greater (p = 0.01) than that in the control group (663 ± 385 N). From 12 weeks to 1 year, the bone flap fixation strengths increased significantly (p < 0.05) for all groups. At 1 year, the flap fixation strength in test group 1 (3240 ± 423 N) and test group 2 (3212 ± 662 N) were both statistically greater (p = 0.04 and p = 0.02, respectively) than that in the control group (2418 ± 1463 N); however, there was no statistically significant difference in the strengths when comparing the test groups at both timepoints. Test group 1 had the best overall performance based on histomorphometric evaluation and biomechanical testing. At 2 years postoperatively, the kerfs filled with TTCP-PS had histological evidence of osteoconduction and replacement of TTCP-PS by bone with nearly complete osteointegration.

CONCLUSIONS

TTCP-PS was demonstrated to be safe and effective for cranial flap fixation in an ovine model. In this study, the bioresorbable, osteoconductive bone adhesive appeared to have multiple advantages over standard plate-and-screw bone flap fixation, including biomechanical superiority, more complete and faster bony healing across the flap kerfs without fibrosis, and the minimization of bone flap and/or hardware migration and loosening. These properties of TTCP-PS may improve human cranial bone flap fixation and cranioplasty.

ABBREVIATIONS TTCP-PS = tetracalcium phosphate and phosphoserine.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Correspondence Brian J. Hess: LaunchPad Medical, Lowell, MA. bhess@launchpadmedical.com.

INCLUDE WHEN CITING Published online February 7, 2020; DOI: 10.3171/2019.11.JNS192806.

Disclosures Funding for this study was provided by Stryker. Drs. Foley, Woodard, and Slotkin are consultants to LaunchPad Medical. Mr. Hess, Mr. Brown, and Ms. Baldwin are employees of LaunchPad Medical. Mrs. Mayotte is an employee of Stryker. Other associations include the following. Dr. Foley: consultant for Medtronic; direct stock ownership in Digital Surgery Systems, Discgenics, DuraStat, Medtronic, NuVasive, nView Medical, Practical Navigation/Fusion Robotics, SpineWave, TDi, and Triad Life Sciences; patent holder with Medtronic and NuVasive; royalties from Medtronic; board of directors of Digital Surgery Systems, Discgenics, DuraStat, LaunchPad Medical, nView Medical, Practical Navigation/Fusion Robotics, TDi, and Triad Life Sciences. Dr. Woodard: ownership in LaunchPad Medical. Dr. Slotkin: direct stock ownership in LaunchPad Medical. Ms. Baldwin: employee of LaunchPad Medical. Mr. Brown: employee and stockholder in LaunchPad Medical. Mr. Hess: ownership in LaunchPad Medical.

  • 1

    Cochran D, Jones A, Sugita R, Brown M, Guda T, Prasad H, : Immediate dental implant stabilization in a canine model using a novel mineral-organic adhesive: four month results. Int J Oral Maxillofac Implants [in press], 2019

    • Search Google Scholar
    • Export Citation
  • 2

    Dashti SR, Baharvahdat H, Spetzler RF, Sauvageau E, Chang SW, Stiefel MF, : Operative intracranial infection following craniotomy. Neurosurg Focus 24(6):E10, 2008

    • Search Google Scholar
    • Export Citation
  • 3

    Donath K, Breuner G: A method for the study of undecalcified bones and teeth with attached soft tissues. The Säge-Schliff (sawing and grinding) technique. J Oral Pathol 11:318326, 1982

    • Search Google Scholar
    • Export Citation
  • 4

    Farrar DF: Bone adhesives for trauma surgery: a review of challenges and developments. Int J Adhes Adhes 33:8997, 2012

  • 5

    Gupta R, Adeeb N, Griessenauer CJ, Moore JM, Patel AS, Thomas AJ, : Removal of symptomatic titanium fixation plates after craniotomy. Acta Neurochir (Wien) 158:18451848, 2016

    • Search Google Scholar
    • Export Citation
  • 6

    Kumar A, Maartens NF, Kaye AH: Evaluation of the use of BioGlue in neurosurgical procedures. J Clin Neurosci 10:661664, 2003

  • 7

    Kwinta BM, Krzyżewski RM, Kliś KM, Donicz P, Gackowska M, Polak J, : Emergency reoperations in cranial neurosurgery. World Neurosurg 105:749754, 2017

    • Search Google Scholar
    • Export Citation
  • 8

    Lindner D, Schlothofer-Schumann K, Kern BC, Marx O, Müns A, Meixensberger J: Cranioplasty using custom-made hydroxyapatite versus titanium: a randomized clinical trial. J Neurosurg 126:175183, 2017

    • Search Google Scholar
    • Export Citation
  • 9

    Moles A, Heudes PM, Amelot A, Cristini J, Salaud C, Roualdes V, : Long-term follow-up comparative study of hydroxyapatite and autologous cranioplasties: complications, cosmetic results, osseointegration. World Neurosurg 111:e395e402, 2018

    • Search Google Scholar
    • Export Citation
  • 10

    Mollman HD, Haines SJ: Risk factors for postoperative neurosurgical wound infection. A case-control study. J Neurosurg 64:902906, 1986

    • Search Google Scholar
    • Export Citation
  • 11

    Motherway JA, Verschueren P, Van der Perre G, Vander Sloten J, Gilchrist MD: The mechanical properties of cranial bone: the effect of loading rate and cranial sampling position. J Biomech 42:21292135, 2009

    • Search Google Scholar
    • Export Citation
  • 12

    Siswanto A, Chong S: Strength analysis of human skull on high speed impact. Int Rev Mech Eng 6:15081514, 2012

  • 13

    Stoker MA, Forbes JA, Hanif R, Cooper C, Nian H, Konrad PE, : Decreased rate of CSF leakage associated with complete reconstruction of suboccipital cranial defects. J Neurol Surg B Skull Base 73:281286, 2012

    • Search Google Scholar
    • Export Citation

Metrics